Using X-ray absorption spectroscopy and microprobe synchrotron radiation-X-ray fluorescence imaging for understanding the mode of action of arsenic anti-leukaemia agents

Understanding the Geological and Medical Interface of Arsenic, As 2012 - 4th International Congress: Arsenic in the Environment

Volumn , Issue , 2012, Pages 193-195

  Munro, K L ^a   Dillon, C T ^a   Harris, H H ^b   Cai, Z ^c   Lai, B ^c   Vogt, S ^c   Cheah, M ^d  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ARGONNE NATIONAL LABORATORY   (United States)

^d National Laboratory for High Energy Physics   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; FLUORESCENCE IMAGING; METABOLISM; METABOLITES; SYNCHROTRON RADIATION; X RAY ABSORPTION SPECTROSCOPY;

ARSENIC SPECIES; DNA TRANSCRIPTIONS; HUMAN HEPATOMA CELLS; MICRO-PROBES; MODE OF ACTION; POTENTIAL TARGETS; SYNCHROTRON RADIATION X-RAY FLUORESCENCE; TOXIC ARSENIC;

ARSENIC;

EID: 84864883310     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1201/b12522-76     Document Type: Conference Paper

References (7)

1. Challenger, F. 1944. "Biological Methylation." Chem Rev. 36: 315-361.
2. Dopp, E., von Recklinghausen, U., Diaz-Bone, R., Hirner, A.V. and Rettenmeier, A.W. 2010. "Cellular uptake, subcellular distribution and toxicity of arsenic compounds in methylating and non-methylating cells." Environ. Res. 110: 435-442.
3. Fujisawa, S., Ohno, R., Shigeno, K., Sahara, N., Nakamura, S., Naito, K., Kobayashi, M., Shinjo, K., Takeshita, A., Suzuki, Y., Hashimoto, H., Kinoshita, K., Shimoya, M., Kaise, T. and Ohnishi, K. 2007. "Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide." Cancer Chemother. Pharmacol. 59: 485-493.
4. Hayakawa, T., Kobayashi, Y., Cui, X. and Hirano, S. 2005. "A new metabolic pathway of arsenite: arsenicglutathione complexes are substrates for human arsenic methyltransferase Cyt19." Arch. Toxicol. 79: 183-191.
5. Munro, K.L., Mariana, A., Klavins, A.I., Foster, A.J., Lai, B., Vogt, S., Cai, Z., Harris, H.H. and Dillon, C.T. 2008. "Microprobe XRF Mapping and XAS Investigations of the Intracellular Metabolism of Arsenic for Understanding Arsenic-Induced Toxicity." Chem. Res. Toxicol. 21: 1760-1769.
6. Rojewski, M.T., Korper, S. and Schrezenmeier, H. 2004. "Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside." Leukemia and Lymphoma 45(12): 2387-2401.
7. Styblo, M., Del Razo, L.M., Vega, L., Germolec, D.R., Le Cluyse, E.L., Hamilton, G.A., Reed, W., Wang, C., Cullen, W.R. and Thomas, D.J. 2000. "Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells." Arch. Toxicol. 74: 289-299.